Arbutus Biopharma Corporation ABUS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's other income (expense)?
- Arbutus Biopharma Corporation (ABUS) reported other income (expense) of $787K in Q1 2026.
- How has Arbutus Biopharma Corporation's other income (expense) changed year-over-year?
- Arbutus Biopharma Corporation's other income (expense) decreased by 32.9% year-over-year, from $1.17M to $787K.
- What is the long-term trend for Arbutus Biopharma Corporation's other income (expense)?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's other income (expense) has grown at a 14.3% compound annual growth rate (CAGR), from -$2.73M to $4.66M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.